rs61752117
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The ENST00000378750.10(PEX16):c.526C>T(p.Arg176Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000062 in 1,614,024 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
ENST00000378750.10 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PEX16 | NM_004813.4 | c.526C>T | p.Arg176Ter | stop_gained | 6/11 | ENST00000378750.10 | NP_004804.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PEX16 | ENST00000378750.10 | c.526C>T | p.Arg176Ter | stop_gained | 6/11 | 1 | NM_004813.4 | ENSP00000368024 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152254Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251424Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135892
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461770Hom.: 0 Cov.: 34 AF XY: 0.00000825 AC XY: 6AN XY: 727190
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152254Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 74382
ClinVar
Submissions by phenotype
Peroxisome biogenesis disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 28, 2023 | This sequence change creates a premature translational stop signal (p.Arg176*) in the PEX16 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PEX16 are known to be pathogenic (PMID: 9837814, 11890679, 20647552, 20681997). This variant is present in population databases (rs61752117, gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with clinical features of Zellweger spectrum disorder (PMID: 9837814, 24091540). ClinVar contains an entry for this variant (Variation ID: 6466). For these reasons, this variant has been classified as Pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jan 02, 2018 | The R176X variant in the PEX16 gene has been reported previously in association with autosomalrecessive Zellweger syndrome when present in the homozygous state or when in trans with anotherpathogenic variant (Honsho et al., 1998; Ohba et al., 2013). One study has shown that the R176Xvariant inactivated PEX16, which impaired peroxisome and peroxisomal membrane vesicle formation(Honsho et al., 1998). This variant is predicted to cause loss of normal protein function either throughprotein truncation or nonsense-mediated mRNA decay. The R176X variant was not observed inapproximately 6500 individuals of European and African American ancestry in the NHLBI ExomeSequencing Project, indicating it is not a common variant in these populations. We interpret R176X as a pathogenic variant. - |
Peroxisome biogenesis disorder 8A (Zellweger) Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 01, 1998 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at